Epitalon (Epithalon) is a synthetic tetrapeptide based on a compound isolated from the pineal gland, studied primarily in Russian longevity research for its proposed effects on telomerase activity and circadian regulation.
The most-cited human data in this space is for Epithalamin/Epithalamine, a peptide preparation (extract) from bovine pineal gland — a mixture of substances, not the single synthetic tetrapeptide. Epitalon (Ala-Glu-Asp-Gly, AEDG) is the specific synthetic 4-amino-acid peptide sold as a research compound, developed based on Epithalamin's composition but not the identical substance that was actually used in the human trial below. This is the same "related-but-different substance" pattern found repeatedly across this research project (e.g. TB-500 vs. the full Thymosin Beta-4 protein) — worth being precise about which one any given claim actually refers to.
Epithalamin, 12-year study, elderly patients with coronary disease and accelerated aging: the treated group had 28% lower overall mortality and roughly 2-fold lower cardiovascular mortality than controls, plus reduced functional cardiovascular aging and improved exercise tolerance. Korkushko et al., Bull Exp Biol Med, 2006 — this is Epithalamin, the pineal extract, not Epitalon the synthetic tetrapeptide.
Epitalon specifically (in vitro, lymphocytes from 76-80-year-old donors): activated ribosomal genes and induced decondensation of structural heterochromatin — a cellular-level finding, not a clinical outcome.
Important limitation on the human data: the Russian elderly-cohort studies in this literature are not double-blind, placebo-controlled, randomized trials — no placebo control, no intention-to-treat analysis, no pre-registered outcome measures. Real, decades-long human data, but a meaningfully weaker design than a modern RCT.
The specific dosing/schedule used in the Epithalamin mortality study wasn't independently confirmed in this pass — and given that study used a different (related) substance than Epitalon itself, its dose wouldn't directly translate to a Epitalon protocol even if it were confirmed. No dose specific to the synthetic Epitalon tetrapeptide was verified.
No dedicated safety/adverse-event breakdown was independently verified for either Epithalamin or Epitalon in this pass.
Longevity, telomerase activity, and sleep/circadian rhythm regulation are the most commonly cited research themes.
No. Most of the supporting research comes from Russian scientific literature and has not been replicated in large Western clinical trials.
It is typically studied via short injection cycles rather than continuous daily use.
There's real, independently replicated evidence. Khavinson's original 2003-2004 work showed it activates telomerase and lets human cells divide past their normal limit — and a 2025 study from an unrelated lab confirmed the telomere-lengthening effect in human cell lines, the kind of independent validation this category doesn't always get.
Animal studies report a 12-24% increase in median and maximum lifespan. Human evidence is much thinner — mostly observational cohort data using the original parent extract, not a randomized controlled trial. The animal data is genuinely strong; the human longevity claim is still an extrapolation.
Looking for something specific, or placing a wholesale order? Send us a DM or email.